Repolarization and depolarization abnormalities are preferentially impaired by ajmaline in Brugada patients compared to controls

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Ventricular arrhythmias management Clinical EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

ESC 365 is supported by

ESC 365 is supported by